Title : Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care - Behrens_2018_Int.Psychogeriatr__1 |
Author(s) : Behrens S , Rattinger GB , Schwartz S , Matyi J , Sanders C , DeBerard MS , Lyketsos CG , Tschanz JT |
Ref : Int Psychogeriatr , :1 , 2018 |
Abstract : |
PubMedSearch : Behrens_2018_Int.Psychogeriatr__1 |
PubMedID: 29559029 |
Title : Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression - Mielke_2012_Alzheimers.Dement_8_180 |
Author(s) : Mielke MM , Leoutsakos JM , Corcoran CD , Green RC , Norton MC , Welsh-Bohmer KA , Tschanz JT , Lyketsos CG |
Ref : Alzheimers Dement , 8 :180 , 2012 |
Abstract : |
PubMedSearch : Mielke_2012_Alzheimers.Dement_8_180 |
PubMedID: 22301194 |